Page last updated: 2024-09-03

l 158809 and Chronic Disease

l 158809 has been researched along with Chronic Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bancalari, E; Camelo, JS; Hehre, D; Martins, AR; Ramos, SG; Rosa, E; Suguihara, C1
Bertani, T; Colosio, V; Corna, D; Donadelli, R; Facchinetti, D; Luzzana, E; Maffi, R; Remuzzi, G; Testa, D; Zoja, C1
Bulagannawar, M; Carretero, OA; Cavasin, MA; Karumanchi, R; Liu, YH; Mehta, D; Yang, XP1
Maki, T; Nasa, Y; Takahashi, M; Takeo, S; Tanonaka, K; Yoshida, H1

Other Studies

4 other study(ies) available for l 158809 and Chronic Disease

ArticleYear
Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2012, Volume: 45, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Antihypertensive Agents; Chronic Disease; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Imidazoles; Immunohistochemistry; Nitric Oxide Synthase; Pulmonary Artery; Swine; Tetrazoles; Vascular Resistance

2012
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1997, Volume: 29, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Extracellular Matrix Proteins; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Imidazoles; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Tetrazoles; Transforming Growth Factor beta

1997
Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
    Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:4

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiac Output; Chronic Disease; Echocardiography; Female; Heart; Heart Failure; Imidazoles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Organ Size; Ramipril; Stroke Volume; Tetrazoles; Ventricular Remodeling

2000
Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.
    British journal of pharmacology, 2001, Volume: 134, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Chronic Disease; Collagen; Dose-Response Relationship, Drug; Fibroblasts; GTP-Binding Proteins; Heart; Heart Failure; Heart Septum; Heart Ventricles; Hemodynamics; Imidazoles; Indoles; Lung; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles

2001